1. Home
  2. SAIC vs LGND Comparison

SAIC vs LGND Comparison

Compare SAIC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$115.60

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$252.98

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
LGND
Founded
1969
1987
Country
United States
United States
Employees
N/A
68
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
SAIC
LGND
Price
$115.60
$252.98
Analyst Decision
Hold
Strong Buy
Analyst Count
8
7
Target Price
$110.50
$256.29
AVG Volume (30 Days)
536.5K
159.7K
Earning Date
06-01-2026
05-07-2026
Dividend Yield
1.56%
N/A
EPS Growth
7.39
N/A
EPS
2.61
N/A
Revenue
$7,262,000,000.00
N/A
Revenue This Year
N/A
$1.25
Revenue Next Year
$1.65
$19.41
P/E Ratio
$44.03
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$81.08
$111.72
52 Week High
$123.41
$258.57

Technical Indicators

Market Signals
Indicator
SAIC
LGND
Relative Strength Index (RSI) 72.56 72.95
Support Level $92.46 $199.97
Resistance Level $123.41 N/A
Average True Range (ATR) 4.56 7.34
MACD 0.60 2.33
Stochastic Oscillator 69.17 87.91

Price Performance

Historical Comparison
SAIC
LGND

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: